Warrants Finder
Your selection:
112 Results
| JE8Z1S | Halozyme Therapeutics Inc./OS/Call [100]/JPMD | - | - | 100.000 | call | Halozyme Therapeutics Inc. | - | 53.130% | 0.342 | -0.023 | 5.272 | 12/18/2026 | 0.100 | JP Morgan | ||
| MM26P7 |  | Halozyme Therapeutics Inc./OS/Call [100]/MS | - | - | 100.000 | call | Halozyme Therapeutics Inc. | - | 51.314% | 0.332 | -0.022 | 5.481 | 12/18/2026 | 0.100 | Morgan Stanley | |
| MM2SE4 | | Halozyme Therapeutics Inc./OS/Call [100]/MS | - | - | 100.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 06/17/2027 | 0.100 | Morgan Stanley | |
| MM5J62 | | Halozyme Therapeutics Inc./OS/Call [100]/MS | - | - | 100.000 | call | Halozyme Therapeutics Inc. | - | 63.559% | 0.243 | -0.036 | 7.589 | 09/18/2026 | 0.100 | Morgan Stanley | |
| MN0311 | | Halozyme Therapeutics Inc./OS/Call [100]/MS | - | - | 100.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 12/17/2027 | 0.100 | Morgan Stanley | |
| MN6DYJ | | Halozyme Therapeutics Inc./OS/Call [100]/MS | - | - | 100.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 03/19/2027 | 0.100 | Morgan Stanley | |
| MM8H8T | | Halozyme Therapeutics Inc./OS/Call [105]/MS | - | - | 105.000 | call | Halozyme Therapeutics Inc. | - | 53.011% | 0.290 | -0.021 | 5.571 | 12/18/2026 | 0.100 | Morgan Stanley | |
| MM8H8S | | Halozyme Therapeutics Inc./OS/Call [105]/MS | - | - | 105.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 06/17/2027 | 0.100 | Morgan Stanley | |
| MM8H8R | | Halozyme Therapeutics Inc./OS/Call [105]/MS | - | - | 105.000 | call | Halozyme Therapeutics Inc. | - | 69.472% | 0.214 | -0.036 | 7.263 | 09/18/2026 | 0.100 | Morgan Stanley | |
| MM3GSL | | Halozyme Therapeutics Inc./OS/Call [110]/MS | - | - | 110.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 06/17/2027 | 0.100 | Morgan Stanley | |
| MM3GSN | | Halozyme Therapeutics Inc./OS/Call [110]/MS | - | - | 110.000 | call | Halozyme Therapeutics Inc. | - | 55.256% | 0.259 | -0.021 | 5.566 | 12/18/2026 | 0.100 | Morgan Stanley | |
| MN2Z3E | | Halozyme Therapeutics Inc./OS/Call [110]/MS | - | - | 110.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 12/17/2027 | 0.100 | Morgan Stanley | |
| MN2Z3F | | Halozyme Therapeutics Inc./OS/Call [110]/MS | - | - | 110.000 | call | Halozyme Therapeutics Inc. | - | 74.929% | 0.192 | -0.036 | 6.986 | 09/18/2026 | 0.100 | Morgan Stanley | |
| MR3CU9 | | Halozyme Therapeutics Inc./OS/Call [110]/MS | - | - | 110.000 | call | Halozyme Therapeutics Inc. | - | 53.075% | 0.303 | -0.016 | 4.498 | 03/19/2027 | 0.100 | Morgan Stanley | |
| MM35ZV | | Halozyme Therapeutics Inc./OS/Call [120]/MS | - | - | 120.000 | call | Halozyme Therapeutics Inc. | - | 64.271% | 0.212 | -0.020 | 5.159 | 12/18/2026 | 0.100 | Morgan Stanley | |
| MN2Z3G | | Halozyme Therapeutics Inc./OS/Call [120]/MS | - | - | 120.000 | call | Halozyme Therapeutics Inc. | - | 86.773% | 0.166 | -0.038 | 6.362 | 09/18/2026 | 0.100 | Morgan Stanley | |
| MR3CUA | | Halozyme Therapeutics Inc./OS/Call [120]/MS | - | - | 120.000 | call | Halozyme Therapeutics Inc. | - | 54.398% | 0.270 | -0.016 | 4.568 | 03/19/2027 | 0.100 | Morgan Stanley | |
| MR3CUC | | Halozyme Therapeutics Inc./OS/Call [120]/MS | - | - | 120.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 12/17/2027 | 0.100 | Morgan Stanley | |
| MR3CUB | | Halozyme Therapeutics Inc./OS/Call [120]/MS | - | - | 120.000 | call | Halozyme Therapeutics Inc. | - | 55.092% | 0.313 | -0.015 | 3.813 | 06/17/2027 | 0.100 | Morgan Stanley | |
| MN5CM3 | | Halozyme Therapeutics Inc./OS/Call [60]/MS | - | - | 60.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 06/17/2027 | 0.100 | Morgan Stanley | |
| MN5CM4 | | Halozyme Therapeutics Inc./OS/Call [60]/MS | - | - | 60.000 | call | Halozyme Therapeutics Inc. | - | 64.454% | 0.834 | -0.021 | 2.659 | 12/18/2026 | 0.100 | Morgan Stanley | |
| MN5CM2 | | Halozyme Therapeutics Inc./OS/Call [60]/MS | - | - | 60.000 | call | Halozyme Therapeutics Inc. | - | 82.283% | 0.864 | -0.035 | 2.994 | 09/18/2026 | 0.100 | Morgan Stanley | |
| MN6DYC | | Halozyme Therapeutics Inc./OS/Call [60]/MS | - | - | 60.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 03/19/2027 | 0.100 | Morgan Stanley | |
| MN6PTH | | Halozyme Therapeutics Inc./OS/Call [60]/MS | - | - | 60.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 12/17/2027 | 0.100 | Morgan Stanley | |
| JE0YPB | Halozyme Therapeutics Inc./OS/Call [62]/JPMD | - | - | 62.000 | call | Halozyme Therapeutics Inc. | - | 60.338% | 0.798 | -0.021 | 2.930 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE111J | Halozyme Therapeutics Inc./OS/Call [64]/JPMD | - | - | 64.000 | call | Halozyme Therapeutics Inc. | - | 80.513% | 0.772 | -0.029 | 2.479 | 12/18/2026 | 0.100 | JP Morgan | ||
| MM26NX | | Halozyme Therapeutics Inc./OS/Call [65]/MS | - | - | 65.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 06/17/2027 | 0.100 | Morgan Stanley | |
| MM26NY | | Halozyme Therapeutics Inc./OS/Call [65]/MS | - | - | 65.000 | call | Halozyme Therapeutics Inc. | - | 58.285% | 0.766 | -0.022 | 3.137 | 12/18/2026 | 0.100 | Morgan Stanley | |
| MM5J5W | | Halozyme Therapeutics Inc./OS/Call [65]/MS | - | - | 65.000 | call | Halozyme Therapeutics Inc. | - | 64.600% | 0.841 | -0.031 | 3.766 | 09/18/2026 | 0.100 | Morgan Stanley | |
| MN501N | | Halozyme Therapeutics Inc./OS/Call [65]/MS | - | - | 65.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 12/17/2027 | 0.100 | Morgan Stanley | |
| MN6DYD | | Halozyme Therapeutics Inc./OS/Call [65]/MS | - | - | 65.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 03/19/2027 | 0.100 | Morgan Stanley | |
| JE1HNE | Halozyme Therapeutics Inc./OS/Call [66]/JPMD | - | - | 66.000 | call | Halozyme Therapeutics Inc. | - | 54.435% | 0.826 | -0.027 | 4.376 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE0YPC | Halozyme Therapeutics Inc./OS/Call [66]/JPMD | - | - | 66.000 | call | Halozyme Therapeutics Inc. | - | 77.703% | 0.756 | -0.029 | 2.590 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE12B7 | Halozyme Therapeutics Inc./OS/Call [68]/JPMD | - | - | 68.000 | call | Halozyme Therapeutics Inc. | - | 66.114% | 0.793 | -0.037 | 3.988 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE111K | Halozyme Therapeutics Inc./OS/Call [68]/JPMD | - | - | 68.000 | call | Halozyme Therapeutics Inc. | - | 57.546% | 0.735 | -0.023 | 3.286 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE1QEA | Halozyme Therapeutics Inc./OS/Call [70]/JPMD | - | - | 70.000 | call | Halozyme Therapeutics Inc. | - | 51.004% | 0.805 | -0.029 | 4.853 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE111H | Halozyme Therapeutics Inc./OS/Call [70]/JPMD | - | - | 70.000 | call | Halozyme Therapeutics Inc. | - | 54.325% | 0.740 | -0.022 | 3.432 | 12/18/2026 | 0.100 | JP Morgan | ||
| MM26NZ | | Halozyme Therapeutics Inc./OS/Call [70]/MS | - | - | 70.000 | call | Halozyme Therapeutics Inc. | - | 54.179% | 0.706 | -0.023 | 3.573 | 12/18/2026 | 0.100 | Morgan Stanley | |
| MM26P0 | | Halozyme Therapeutics Inc./OS/Call [70]/MS | - | - | 70.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 06/17/2027 | 0.100 | Morgan Stanley | |
| MM5J5X | | Halozyme Therapeutics Inc./OS/Call [70]/MS | - | - | 70.000 | call | Halozyme Therapeutics Inc. | - | 42.299% | 0.778 | -0.025 | 5.898 | 09/18/2026 | 0.100 | Morgan Stanley | |
| MN030W | | Halozyme Therapeutics Inc./OS/Call [70]/MS | - | - | 70.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 12/17/2027 | 0.100 | Morgan Stanley | |
| MN6DYE | | Halozyme Therapeutics Inc./OS/Call [70]/MS | - | - | 70.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 03/19/2027 | 0.100 | Morgan Stanley | |
| JE12AY | Halozyme Therapeutics Inc./OS/Call [72]/JPMD | - | - | 72.000 | call | Halozyme Therapeutics Inc. | - | 51.168% | 0.759 | -0.032 | 5.178 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE0YP8 | Halozyme Therapeutics Inc./OS/Call [72]/JPMD | - | - | 72.000 | call | Halozyme Therapeutics Inc. | - | 54.124% | 0.712 | -0.023 | 3.558 | 12/18/2026 | 0.100 | JP Morgan | ||
| JZ9X22 | Halozyme Therapeutics Inc./OS/Call [74]/JPMD | - | - | 74.000 | call | Halozyme Therapeutics Inc. | - | 60.128% | 0.697 | -0.041 | 4.896 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE111N | Halozyme Therapeutics Inc./OS/Call [74]/JPMD | - | - | 74.000 | call | Halozyme Therapeutics Inc. | - | 53.385% | 0.685 | -0.024 | 3.710 | 12/18/2026 | 0.100 | JP Morgan | ||
| MM26P1 | | Halozyme Therapeutics Inc./OS/Call [75]/MS | - | - | 75.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 06/17/2027 | 0.100 | Morgan Stanley | |
| MM26P2 | | Halozyme Therapeutics Inc./OS/Call [75]/MS | - | - | 75.000 | call | Halozyme Therapeutics Inc. | - | 51.195% | 0.673 | -0.023 | 3.886 | 12/18/2026 | 0.100 | Morgan Stanley | |
| MM5J5Y | | Halozyme Therapeutics Inc./OS/Call [75]/MS | - | - | 75.000 | call | Halozyme Therapeutics Inc. | - | 47.226% | 0.701 | -0.033 | 5.992 | 09/18/2026 | 0.100 | Morgan Stanley | |
| MN030X | | Halozyme Therapeutics Inc./OS/Call [75]/MS | - | - | 75.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 12/17/2027 | 0.100 | Morgan Stanley |